MAPK1 and Parkinson disease: Yan et al. reported that a CoQ10 analog, idebenone, exhibits a suppressive effect on neuroinflammation microglial phenotype in an MPTP-stressed PD mouse model by inhibiting Mitogen-Activated Protein Kinase 1/3 (MAPK1/3) and the NFκB signaling pathway [122].